Analystreport

WAVE Life Sciences (NASDAQ:WVE) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $18.00 price target on the stock.

Wave Life Sciences Ltd. - Ordinary Shares  (WVE) 
Last wave life sciences ltd. - ordinary shares earnings: 3/2 06:45 am Check Earnings Report